National Center for Research Resources; Notice of Closed Meetings

Download PDF
Federal RegisterNov 10, 2004
69 Fed. Reg. 65203 (Nov. 10, 2004)

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Center for Research Resources Special Emphasis Panel, Scientific and Technical Review Board.

Date: November 10, 2004.

Time: 10 a.m. to Adjournment.

Agenda: To review and evaluate grant applications.

Place: Office of Review, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Barbara J. Nelson, PhD, Office of Review, National Center for Research Resources, NIH, 6701 Democracy Blvd., Room 1080, 1 Democracy Plaza, Bethesda, MD 20892, (301) 435-0806.

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

Name of Committee: National Center for Research Resources Special Emphasis Panel, General Clinic Research Center.

Date: November 30-December 1, 2004.

Time: November 30, 2004, 8 a.m. to Adjournment.

Agenda: To review and evaluate grant applications.

Place: Embassy Suites Hotel, 1881 Curtis Street, Denver, CO 80202.

Contact Person: Eva Petrakova, PhD, Scientific Review Administrator, Office of Review, NCRR, National Institutes of Health, 6701 Democracy Boulevard, 1 Democracy Plaza, Room 1066, MSC 4874, Bethesda, MD 20817-4874, (301) 435-0965, petrakoe@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, National Institutes of Health, HHS)

Dated: November 2, 2004.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 04-25021 Filed 11-9-04; 8:45 am]

BILLING CODE 4140-01-M